Literature DB >> 1261401

[Intrahepatic cholestasis due to N-propyl ajmaline].

H P Buscher, H Talke, H P Rademacher, U Gessner, W Oehlert, W Gerok.   

Abstract

In two patients intrahepatic cholestasis and cholestatic liver disease probably due to N-propyl ajmaline were observed. In both cases there was a four-week-interval between the first ingestion of the drug and the onset of jaundice. In one case with rigors there was a temporary rise in temperature and cholestasis. In the other there was a two to three week prodromal period of pruritus and gastro-intestinal symptoms. Both cases were characterised by blood and pronounced tissue eosinophilia in the periportal zones, a marked increase of cholestatic and hepatic cell enzymes, serum bilirubin and cholesterol, a moderate increase in erythrocyte sedimentation rate and absence of leucocytosis. Pathological laboratory findings returned to normal spontaneously within 5 weeks in one case and within two weeks under steroid therapy in the other.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1261401     DOI: 10.1055/s-0028-1104163

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  4 in total

Review 1.  Adverse effects of antiarrhythmic drugs.

Authors:  J B Schwartz; D Keefe; D C Harrison
Journal:  Drugs       Date:  1981-01       Impact factor: 9.546

2.  Cholestatic jaundice: an immune response to prajmalium bitartrate.

Authors:  H H Rotmensch; M Liron; I Yust; A Klejman; E Livni; T Moalem; A Gefel
Journal:  Postgrad Med J       Date:  1980-10       Impact factor: 2.401

3.  Prajmaliumbitartrate-associated liver damage. Report on seven further cases with follow-up for two to five years.

Authors:  G Börsch; G Schmidt; G Hopmann; T Surmann; G Sabin; D Ricken
Journal:  Klin Wochenschr       Date:  1984-10-15

4.  [Intrahepatic cholestasis and aplastic anemia following administration of prajmaline].

Authors:  R Lenzen; H Gottesbüren; F Borchard; M Wienbeck; G Strohmeyer
Journal:  Klin Wochenschr       Date:  1988-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.